Director buying more shares. No particular reason for it is obvious, so perhaps things are just going well. Very undervalued IMO.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025